These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Hepatitis C virus and glucose and lipid metabolism. Alaei M; Negro F Diabetes Metab; 2008 Dec; 34(6 Pt 2):692-700. PubMed ID: 19195632 [TBL] [Abstract][Full Text] [Related]
6. Insulin resistance among patients with chronic hepatitis C: etiology and impact on treatment. Harrison SA Clin Gastroenterol Hepatol; 2008 Aug; 6(8):864-76. PubMed ID: 18585970 [TBL] [Abstract][Full Text] [Related]
7. [The pathological mechanisms of glycoregulation disturbances in chronic hepatitis B and C]. Paraschiv C; Graur M; Butnariu G; Mihai B; Constantinescu D Rev Med Chir Soc Med Nat Iasi; 2002; 107(2):294-7. PubMed ID: 12638277 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis C and diabetes mellitus. Banerjee S; Banerjee M J Indian Med Assoc; 2006 Feb; 104(2):86-9. PubMed ID: 16856589 [TBL] [Abstract][Full Text] [Related]
9. High prevalence of diabetes mellitus in patients with chronic hepatitis C. A case-control study. Grimbert S; Valensi P; Lévy-Marchal C; Perret G; Richardet JP; Raffoux C; Trinchet JC; Beaugrand M Gastroenterol Clin Biol; 1996; 20(6-7):544-8. PubMed ID: 8881566 [TBL] [Abstract][Full Text] [Related]
10. Decreased beta cell reserve and higher prevalence of vascular complications in cirrhotics who developed diabetes mellitus. Sampelean D; Casoinic F; Orasan O J Gastrointestin Liver Dis; 2010 Jun; 19(2):221-2. PubMed ID: 20593064 [No Abstract] [Full Text] [Related]
11. Steatosis, insulin resistance and fibrosis progression in chronic hepatitis C. Castera L Minerva Gastroenterol Dietol; 2006 Jun; 52(2):125-34. PubMed ID: 16557184 [TBL] [Abstract][Full Text] [Related]
15. Insulin resistance and response to antiviral therapy in chronic hepatitis C: mechanisms and management. del Campo JA; López RA; Romero-Gómez M Dig Dis; 2010; 28(1):285-93. PubMed ID: 20460925 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus-associated insulin resistance: pathogenic mechanisms and clinical implications. Hung CH; Lee CM; Lu SN Expert Rev Anti Infect Ther; 2011 May; 9(5):525-33. PubMed ID: 21609264 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis C and the risk of cardiovascular disease: an evolving epidemic? Aytaman A; McFarlane SI Expert Rev Cardiovasc Ther; 2006 Jul; 4(4):439-42. PubMed ID: 16918263 [No Abstract] [Full Text] [Related]
18. Hepatic steatosis and insulin resistance are associated with severe fibrosis in patients with chronic hepatitis caused by HBV or HCV infection. Petta S; Cammà C; Di Marco V; Macaluso FS; Maida M; Pizzolanti G; Belmonte B; Cabibi D; Di Stefano R; Ferraro D; Guarnotta C; Venezia G; Craxì A Liver Int; 2011 Apr; 31(4):507-15. PubMed ID: 21382161 [TBL] [Abstract][Full Text] [Related]
19. [Post-transplant diabetes mellitus associated with acute hepatitis C virus infection in a renal transplant recipient]. Gavela E; Crespo JF; Sancho A; Avila A; Núñez A; Molina P; Pallardó LM Nefrologia; 2004; 24(1):75-8. PubMed ID: 15083962 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis C infection and diabetes. Noto H; Raskin P J Diabetes Complications; 2006; 20(2):113-20. PubMed ID: 16504840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]